Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)Shares Outstanding
Ratios

Abeona Therapeutics (ABEO) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Abeona Therapeutics (ABEO) over the last 14 years, with Q3 2025 value amounting to $600000.0.

  • Abeona Therapeutics' Accumulated Depreciation & Amortization rose 2000.0% to $600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $600000.0, marking a year-over-year increase of 2000.0%. This contributed to the annual value of $2.0 million for FY2024, which is 1304.35% down from last year.
  • As of Q3 2025, Abeona Therapeutics' Accumulated Depreciation & Amortization stood at $600000.0, which was up 2000.0% from $600000.0 recorded in Q2 2025.
  • Abeona Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $3.3 million during Q4 2021, with a 5-year trough of $500000.0 in Q3 2023.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $800000.0 (2021), whereas its average is $1.1 million.
  • As far as peak fluctuations go, Abeona Therapeutics' Accumulated Depreciation & Amortization crashed by 3750.0% in 2023, and later soared by 2000.0% in 2025.
  • Over the past 5 years, Abeona Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $3.3 million in 2021, then dropped by 6.06% to $3.1 million in 2022, then dropped by 25.81% to $2.3 million in 2023, then dropped by 13.04% to $2.0 million in 2024, then plummeted by 70.0% to $600000.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $600000.0 for Q3 2025, versus $600000.0 for Q2 2025 and $500000.0 for Q1 2025.